The cardiovascular devices market size has grown strongly in recent years. It will grow from $72.22 billion in 2025 to $76.6 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of interventional cardiology procedures, improvements in surgical techniques, growing availability of cardiac care infrastructure, increased use of implantable cardiac devices.
The cardiovascular devices market size is expected to see strong growth in the next few years. It will grow to $100.37 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing demand for structural heart interventions, rising adoption of AI-assisted cardiac diagnostics, expansion of outpatient cardiovascular procedures, growing investments in next-generation cardiovascular devices, continuous innovation in biocompatible and smart materials. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular devices, rising use of transcatheter therapies, growing integration of advanced imaging-guided interventions, expansion of remote cardiac monitoring solutions, enhanced focus on device miniaturization and precision.
The rising prevalence of cardiovascular disorders is expected to drive growth in the cardiovascular device market in the coming years. Cardiovascular disorders include medical conditions affecting the heart and blood vessels, encompassing a range of diseases involving the circulatory system. This prevalence is increasing due to factors such as aging populations, sedentary lifestyles, poor diet, and rising rates of hypertension and diabetes. The cardiovascular device market supports this trend by providing devices that assist heart function and maintain blood flow in patients with weakened or failing hearts. For instance, in January 2024, according to the American Heart Association, a U.S.-based nonprofit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, up 4% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disorders is fueling the cardiovascular device market.
The growth of the cardiovascular device market is further supported by rising healthcare expenditure. Healthcare expenditure refers to the total financial resources spent on medical treatments, hospital care, medications, and public health initiatives by governments, businesses, and individuals. The demand for healthcare spending is rising due to the growing prevalence of chronic diseases, which often require long-term and costly treatment. Higher healthcare expenditure enables the adoption of advanced cardiovascular treatment technologies, improves access to life-saving procedures, supports better hospital infrastructure, and facilitates early diagnosis and high-quality patient care. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing a 0.9% rise compared to 2022. Consequently, growing healthcare expenditure is driving the cardiovascular device market.
Leading companies in the cardiovascular devices market are focusing on developing advanced interventional solutions, such as drug-coated balloon catheters, to address complex coronary conditions and improve long-term outcomes. A drug-coated balloon catheter is a minimally invasive device that dilates a narrowed coronary artery segment while simultaneously delivering an antiproliferative drug, such as paclitaxel, to the arterial wall. This helps prevent restenosis without leaving a permanent scaffold. For instance, in March 2024, Boston Scientific, a U.S.-based medical device company, received U.S. FDA approval for its Agent drug-coated balloon catheter, the first of its kind for treating coronary in-stent restenosis (ISR). The device demonstrated significant efficacy in reducing the recurrence of vessel narrowing in a study of 480 patients, offering interventional cardiologists a non-stent alternative for ISR management.
Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.
North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the cardiovascular devices market by increasing costs of imported stents, catheters, implantable devices, imaging systems, and specialized surgical equipment. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported high-value devices, while Asia-Pacific faces higher production and export costs. These tariffs are increasing procedural costs and influencing purchasing decisions. At the same time, they are encouraging regional manufacturing, domestic device innovation, and diversification of cardiovascular device supply chains.
The cardiovascular devices market research report is one of a series of new reports that provides cardiovascular devices market statistics, including cardiovascular devices industry global market size, regional shares, competitors with a cardiovascular devices market share, detailed cardiovascular devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular devices industry. This cardiovascular devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular devices play a crucial role in the monitoring and management of irregular heartbeats and heart rhythm disorders.
The cardiovascular devices market encompasses various key categories, including cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, as well as cardiac assist devices and equipment. Defibrillators are instrumental devices that restore a normal heartbeat by delivering an electric pulse or shock to the heart. They are utilized to prevent or correct arrhythmias, which involve irregular, slow, or fast heartbeats. The sources of funding for these devices can be either public or private, while the products used include instruments/equipment and disposables. These devices serve a range of end-users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The cardiovascular devices market consists of sales of biventricular devices, and implantable cardiac loop recorders that are used for monitoring and treatment of cardiovascular disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiovascular devices market size is expected to see strong growth in the next few years. It will grow to $100.37 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing demand for structural heart interventions, rising adoption of AI-assisted cardiac diagnostics, expansion of outpatient cardiovascular procedures, growing investments in next-generation cardiovascular devices, continuous innovation in biocompatible and smart materials. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular devices, rising use of transcatheter therapies, growing integration of advanced imaging-guided interventions, expansion of remote cardiac monitoring solutions, enhanced focus on device miniaturization and precision.
The rising prevalence of cardiovascular disorders is expected to drive growth in the cardiovascular device market in the coming years. Cardiovascular disorders include medical conditions affecting the heart and blood vessels, encompassing a range of diseases involving the circulatory system. This prevalence is increasing due to factors such as aging populations, sedentary lifestyles, poor diet, and rising rates of hypertension and diabetes. The cardiovascular device market supports this trend by providing devices that assist heart function and maintain blood flow in patients with weakened or failing hearts. For instance, in January 2024, according to the American Heart Association, a U.S.-based nonprofit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, up 4% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disorders is fueling the cardiovascular device market.
The growth of the cardiovascular device market is further supported by rising healthcare expenditure. Healthcare expenditure refers to the total financial resources spent on medical treatments, hospital care, medications, and public health initiatives by governments, businesses, and individuals. The demand for healthcare spending is rising due to the growing prevalence of chronic diseases, which often require long-term and costly treatment. Higher healthcare expenditure enables the adoption of advanced cardiovascular treatment technologies, improves access to life-saving procedures, supports better hospital infrastructure, and facilitates early diagnosis and high-quality patient care. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing a 0.9% rise compared to 2022. Consequently, growing healthcare expenditure is driving the cardiovascular device market.
Leading companies in the cardiovascular devices market are focusing on developing advanced interventional solutions, such as drug-coated balloon catheters, to address complex coronary conditions and improve long-term outcomes. A drug-coated balloon catheter is a minimally invasive device that dilates a narrowed coronary artery segment while simultaneously delivering an antiproliferative drug, such as paclitaxel, to the arterial wall. This helps prevent restenosis without leaving a permanent scaffold. For instance, in March 2024, Boston Scientific, a U.S.-based medical device company, received U.S. FDA approval for its Agent drug-coated balloon catheter, the first of its kind for treating coronary in-stent restenosis (ISR). The device demonstrated significant efficacy in reducing the recurrence of vessel narrowing in a study of 480 patients, offering interventional cardiologists a non-stent alternative for ISR management.
Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.
North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the cardiovascular devices market by increasing costs of imported stents, catheters, implantable devices, imaging systems, and specialized surgical equipment. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported high-value devices, while Asia-Pacific faces higher production and export costs. These tariffs are increasing procedural costs and influencing purchasing decisions. At the same time, they are encouraging regional manufacturing, domestic device innovation, and diversification of cardiovascular device supply chains.
The cardiovascular devices market research report is one of a series of new reports that provides cardiovascular devices market statistics, including cardiovascular devices industry global market size, regional shares, competitors with a cardiovascular devices market share, detailed cardiovascular devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular devices industry. This cardiovascular devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular devices play a crucial role in the monitoring and management of irregular heartbeats and heart rhythm disorders.
The cardiovascular devices market encompasses various key categories, including cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, as well as cardiac assist devices and equipment. Defibrillators are instrumental devices that restore a normal heartbeat by delivering an electric pulse or shock to the heart. They are utilized to prevent or correct arrhythmias, which involve irregular, slow, or fast heartbeats. The sources of funding for these devices can be either public or private, while the products used include instruments/equipment and disposables. These devices serve a range of end-users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
The cardiovascular devices market consists of sales of biventricular devices, and implantable cardiac loop recorders that are used for monitoring and treatment of cardiovascular disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cardiovascular Devices Market Characteristics
3. Cardiovascular Devices Market Supply Chain Analysis
4. Global Cardiovascular Devices Market Trends and Strategies
5. Cardiovascular Devices Market Analysis of End Use Industries
7. Global Cardiovascular Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cardiovascular Devices Total Addressable Market (TAM) Analysis for the Market
9. Cardiovascular Devices Market Segmentation
10. Cardiovascular Devices Market Regional and Country Analysis
11. Asia-Pacific Cardiovascular Devices Market
12. China Cardiovascular Devices Market
13. India Cardiovascular Devices Market
14. Japan Cardiovascular Devices Market
15. Australia Cardiovascular Devices Market
16. Indonesia Cardiovascular Devices Market
17. South Korea Cardiovascular Devices Market
18. Bangladesh Cardiovascular Devices Market
19. Thailand Cardiovascular Devices Market
20. Vietnam Cardiovascular Devices Market
21. Malaysia Cardiovascular Devices Market
22. Singapore Cardiovascular Devices Market
23. Philippines Cardiovascular Devices Market
24. Hong Kong Cardiovascular Devices Market
25. New Zealand Cardiovascular Devices Market
26. Taiwan Cardiovascular Devices Market
27. South East Asia Cardiovascular Devices Market
28. Western Europe Cardiovascular Devices Market
29. UK Cardiovascular Devices Market
30. Germany Cardiovascular Devices Market
31. France Cardiovascular Devices Market
32. Italy Cardiovascular Devices Market
33. Spain Cardiovascular Devices Market
34. Austria Cardiovascular Devices Market
35. Belgium Cardiovascular Devices Market
36. Denmark Cardiovascular Devices Market
37. Finland Cardiovascular Devices Market
38. Ireland Cardiovascular Devices Market
39. Netherlands Cardiovascular Devices Market
40. Norway Cardiovascular Devices Market
41. Portugal Cardiovascular Devices Market
42. Sweden Cardiovascular Devices Market
42. Switzerland Cardiovascular Devices Market
43. Eastern Europe Cardiovascular Devices Market
44. Russia Cardiovascular Devices Market
45. Czech Republic Cardiovascular Devices Market
46. Poland Cardiovascular Devices Market
47. Romania Cardiovascular Devices Market
48. Ukraine Cardiovascular Devices Market
49. North America Cardiovascular Devices Market
50. USA Cardiovascular Devices Market
51. Canada Cardiovascular Devices Market
52. Mexico Cardiovascular Devices Market
53. South America Cardiovascular Devices Market
54. Brazil Cardiovascular Devices Market
55. Chile Cardiovascular Devices Market
56. Argentina Cardiovascular Devices Market
57. Colombia Cardiovascular Devices Market
58. Peru Cardiovascular Devices Market
59. Middle East Cardiovascular Devices Market
60. Saudi Arabia Cardiovascular Devices Market
61. Israel Cardiovascular Devices Market
62. Iran Cardiovascular Devices Market
63. Turkey Cardiovascular Devices Market
64. United Arab Emirates Cardiovascular Devices Market
65. Africa Cardiovascular Devices Market
66. Egypt Cardiovascular Devices Market
67. Nigeria Cardiovascular Devices Market
68. South Africa Cardiovascular Devices Market
70. Cardiovascular Devices Market Competitive Landscape and Company Profiles
71. Cardiovascular Devices Market Other Major and Innovative Companies
74. Cardiovascular Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Cardiovascular Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiovascular devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiovascular devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Cardiovascular Surgery Devices And Equipment; Cardiac Rhythm Management (CRM) Devices And Equipment; Interventional Cardiology Devices And Equipment; Defibrillator Devices And Equipment; Peripheral Vascular Devices And Equipment; Prosthetic Heart Valve Devices And Equipment; Electrophysiology Devices And Equipment; Cardiac Assist Devices And Equipment2) By Type of Expenditure: Public; Private
3) By End User: Hospitals And Clinics; Cardiac Care Centers And Specialty Clinics; Other End Users
Subsegments:
1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment; Heart Valve Repair And Replacement Devices; Aortic Aneurysm Repair Devices; Cardiopulmonary Bypass Equipment; Other Cardiovascular Surgery Devices2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers; Defibrillators; Cardiac Resynchronization Therapy (CRT) Devices
3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal); Catheters (Balloon, Diagnostic, Guiding); Angioplasty Equipment; Guidewires; Other Interventional Cardiology Devices
4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs); Automated External Defibrillators (AEDs); Wearable Defibrillators; External Defibrillators
5) By Peripheral Vascular Devices And Equipment: Peripheral Stents; Balloons (Peripheral Angioplasty); Embolic Protection Devices; Endovenous Laser Devices; Other Peripheral Vascular Devices
6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves (TAVR); Other Prosthetic Heart Valve Devices
7) By Electrophysiology Devices And Equipment: Ablation Catheters; Electrophysiology Mapping Systems; ECG And EKG Systems; Cardiac Mapping And Navigation Systems; Other Electrophysiology Devices
8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs); Intra-Aortic Balloon Pumps; Total Artificial Heart; Extracorporeal Membrane Oxygenation (ECMO); Other Cardiac Assist Devices
Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Edwards Lifesciences Corporation; Johnson & Johnson; Terumo Corporation; Getinge AB; Teleflex Incorporated; Becton Dickinson and Company; Siemens Healthineers AG; Fresenius SE & Co. KGaA; GE HealthCare Technologies Inc.; Stryker Corporation; B. Braun Medical Pvt. Ltd.; Baxter International Inc.; Fujifilm Holdings Corporation; Canon Medical Systems Corporation; MicroPort Scientific America Inc.; W. L. Gore & Associates Inc.; AngioDynamics Inc.; CryoLife Inc.; Endologix LLC; Lombard Medical Limited; Avinger Inc.; Abiomed Inc.; Biosensors International Group Ltd.; Biotronik SE & Co. KG; CeloNova BioSciences Inc.; LeMaitre Vascular Inc.
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiovascular Devices market report include:- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Edwards Lifesciences Corporation
- Johnson & Johnson
- Terumo Corporation
- Getinge AB
- Teleflex Incorporated
- Becton Dickinson and Company
- Siemens Healthineers AG
- Fresenius SE & Co. KGaA
- GE HealthCare Technologies Inc.
- Stryker Corporation
- B. Braun Medical Pvt. Ltd.
- Baxter International Inc.
- Fujifilm Holdings Corporation
- Canon Medical Systems Corporation
- MicroPort Scientific America Inc.
- W. L. Gore & Associates Inc.
- AngioDynamics Inc.
- CryoLife Inc.
- Endologix LLC
- Lombard Medical Limited
- Avinger Inc.
- Abiomed Inc.
- Biosensors International Group Ltd.
- Biotronik SE & Co. KG
- CeloNova BioSciences Inc.
- LeMaitre Vascular Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 76.6 Billion |
| Forecasted Market Value ( USD | $ 100.37 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
